Shiela M Strauss

Faculty

Shiela Strauss headshot

Shiela M Strauss

Associate Professor

1 212 998 5280

433 FIRST AVENUE
NEW YORK, NY 10010
United States

A Principal Investigator since 1999 on grants funded by NIH and private foundations, Dr. Strauss’ research has primarily focused on studying the drug treatment response to the hepatitis C virus, and support for alcohol reduction among HIV positive patients. Dr. Strauss has also applied innovative statistical methodology to examine the validity of self-report of HIV status among out-of-treatment drug users. A more recent focus has involved an examination of the relationship between periodontal disease and diabetes, and the potential of the dental office to serve as a site for diabetes screening.

PhD, 1996, Graduate School and University Center of the City University of New York;
MA, 1972, Lehman College of the City University of New York;
BS, 1967, City College of the City University of New York

Women's health
Oral-systemic health
Non-communicable disease
Infectious disease

Jewish Diabetes Association;
Phi Beta Kappa

Fulbright Senior Specialist Award: Bringing the hepatitis C research to Israel and the Middle East; (2005)
1996, Dissertation Year Fellowship Award: Graduate School and University Center of the City University of New York; (1996)
Edyth May Sliffe Award for Distinguished High School Mathematics Teaching, Mathematics Association of America; (1989)
Presidential Scholars Program Certificate of Excellence, The White House; (1988)
Election to Phi Beta Kappa (1966)

Hepatitis C knowledge among staff in U.S. drug treatment programs

Failed retrieving data.

Providing support to drug users infected with hepatitis C: The role of methadone maintenance treatment staff

Failed retrieving data.

Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs

Failed retrieving data.

Stigma 2: Hepatitus C and drug abuse

Failed retrieving data.

Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.

Failed retrieving data.

HCV pre- and post-test counseling services at drug treatment programs: Missed opportunities for primary prevention

Failed retrieving data.

Hepatitis C Service Delivery in Prisons: Peer Education From the “Guys in Blue”

Failed retrieving data.

Integrating hepatitis C services into existing HIV services: The experiences of a sample of U.S. drug treatment units

Failed retrieving data.

Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection

Failed retrieving data.

Residential substance user treatment programs as venues for HCV pharmacological treatment: Client and staff perspectives

Failed retrieving data.